Cargando…

Evofosfamide Is Effective against Pediatric Aggressive Glioma Cell Lines in Hypoxic Conditions and Potentiates the Effect of Cytotoxic Chemotherapy and Ionizing Radiations

SIMPLE SUMMARY: Despite many therapeutic approaches attempted over the last years, the prognosis of children with high-grade glioma or diffuse intrinsic pontine glioma remains dismal. Hypoxia-activated prodrugs (HAPs) were developed to target hypoxic areas within solid tumors as gliomas. Evofosfamid...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bailleul, Quentin, Navarin, Pauline, Arcicasa, Mélanie, Bal-Mahieu, Christine, Carcaboso, Angel Montero, Le Bourhis, Xuefen, Furlan, Alessandro, Meignan, Samuel, Leblond, Pierre
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8070185/ https://www.ncbi.nlm.nih.gov/pubmed/33918823 http://dx.doi.org/10.3390/cancers13081804

Ejemplares similares

H3.3K27M Mutation Controls Cell Growth and Resistance to Therapies in Pediatric Glioma Cell Lines
por: Rakotomalala, Andria, et al.
Publicado: (2021)

Deep-learning and MR images to target hypoxic habitats with evofosfamide in preclinical models of sarcoma
por: Jardim-Perassi, Bruna V., et al.
Publicado: (2021)

Vimentin Promotes the Aggressiveness of Triple Negative Breast Cancer Cells Surviving Chemotherapeutic Treatment
por: Winter, Marie, et al.
Publicado: (2021)

The hypoxia-activated prodrug evofosfamide in combination with multiple regimens of radiotherapy
por: Nytko, Katarzyna J., et al.
Publicado: (2017)

(18)F-fluoromisonidazole predicts evofosfamide uptake in pancreatic tumor model
por: Grkovski, Milan, et al.
Publicado: (2018)

Evofosfamide sensitizes esophageal carcinomas to radiation without increasing normal tissue toxicity
por: Spiegelberg, Linda, et al.
Publicado: (2019)

Evofosfamide for the treatment of human papillomavirus-negative head and neck squamous cell carcinoma
por: Jamieson, Stephen M.F., et al.
Publicado: (2023)

Efficacy of the hypoxia-activated prodrug evofosfamide (TH-302) in nasopharyngeal carcinoma in vitro and in vivo
por: Huang, Yan, et al.
Publicado: (2018)

Hypoxia Imaging With PET Correlates With Antitumor Activity of the Hypoxia-Activated Prodrug Evofosfamide (TH-302) in Rodent Glioma Models
por: Stokes, Ashley M., et al.
Publicado: (2016)

Enhancement of Breast Cancer Cell Aggressiveness by lncRNA H19 and its Mir-675 Derivative: Insight into Shared and Different Actions
por: Peperstraete, Evodie, et al.
Publicado: (2020)

Hypoxia-Targeting Drug Evofosfamide (TH-302) Enhances Sunitinib Activity in Neuroblastoma Xenograft Models()
por: Kumar, Sushil, et al.
Publicado: (2018)

An Intratumor Pharmacokinetic/Pharmacodynamic Model for the Hypoxia-Activated Prodrug Evofosfamide (TH-302): Monotherapy Activity is Not Dependent on a Bystander Effect()()
por: Hong, Cho Rong, et al.
Publicado: (2018)

Anticancer efficacy of the hypoxia‐activated prodrug evofosfamide (TH‐302) in osteolytic breast cancer murine models
por: Liapis, Vasilios, et al.
Publicado: (2016)

Anticancer efficacy of the hypoxia‐activated prodrug evofosfamide is enhanced in combination with proapoptotic receptor agonists against osteosarcoma
por: Liapis, Vasilios, et al.
Publicado: (2017)

Targeting Hypoxia Using Evofosfamide and Companion Hypoxia Imaging of FMISO-PET in Advanced Biliary Tract Cancer
por: Yoon, Jeesun, et al.
Publicado: (2021)

Phase 2 trial of hypoxia activated evofosfamide (TH302) for treatment of recurrent bevacizumab-refractory glioblastoma
por: Brenner, Andrew J., et al.
Publicado: (2021)

Development of a human in vitro blood–brain tumor barrier model of diffuse intrinsic pontine glioma to better understand the chemoresistance
por: Deligne, Clémence, et al.
Publicado: (2020)

Impact of Tumour Hypoxia on Evofosfamide Sensitivity in Head and Neck Squamous Cell Carcinoma Patient-Derived Xenograft Models
por: Harms, Julia K., et al.
Publicado: (2019)

Circulating metabolites associated with tumor hypoxia and early response to treatment in bevacizumab-refractory glioblastoma after combined bevacizumab and evofosfamide
por: Lodi, Alessia, et al.
Publicado: (2022)

A Novel PBPK Modeling Approach to Assess Cytochrome P450 Mediated Drug‐Drug Interaction Potential of the Cytotoxic Prodrug Evofosfamide
por: Lüpfert, Christian, et al.
Publicado: (2018)

A Combination of Radiation and the Hypoxia-Activated Prodrug Evofosfamide (TH-302) is Efficacious against a Human Orthotopic Pancreatic Tumor Model()()
por: Hajj, Carla, et al.
Publicado: (2017)

NGF-induced TrkA/CD44 association is involved in tumor aggressiveness and resistance to lestaurtinib
por: Aubert, Léo, et al.
Publicado: (2015)

Combining genotypic and phenotypic analyses on single mutant zebrafish larvae
por: Dupret, Barbara, et al.
Publicado: (2018)

Regulation of Human Breast Cancer by the Long Non-Coding RNA H19
por: Collette, Jordan, et al.
Publicado: (2017)

Resistance of Hypoxic Cells to Ionizing Radiation Is Mediated in Part via Hypoxia-Induced Quiescence
por: Menegakis, Apostolos, et al.
Publicado: (2021)

Hypoxia in Solid Tumors: How Low Oxygenation Impacts the “Six Rs” of Radiotherapy
por: Rakotomalala, Andria, et al.
Publicado: (2021)

A Bloody Conspiracy— Blood Vessels and Immune Cells in the Tumor Microenvironment
por: Terrassoux, Lisa, et al.
Publicado: (2022)

(18)F-FMISO PET Imaging Identifies Hypoxia and Immunosuppressive Tumor Microenvironments and Guides Targeted Evofosfamide Therapy in Tumors Refractory to PD-1 and CTLA-4 Inhibition
por: Reeves, Kirsten M., et al.
Publicado: (2022)

Macrophage-Colony-Stimulating Factor Receptor Enhances Prostate Cancer Cell Growth and Aggressiveness In Vitro and In Vivo and Increases Osteopontin Expression
por: Mougel, Alexandra, et al.
Publicado: (2022)

A phase 1 ‘window-of-opportunity’ trial testing evofosfamide (TH-302), a tumour-selective hypoxia-activated cytotoxic prodrug, with preoperative chemoradiotherapy in oesophageal adenocarcinoma patients
por: Larue, Ruben T. H. M., et al.
Publicado: (2016)

Propagation and Maintenance of Cancer Stem Cells: A Major Influence of the Long Non-Coding RNA H19
por: Lecerf, Clément, et al.
Publicado: (2020)

Protective Effect of Hypoxic Preconditioning on Hypoxic-Ischemic Injured Newborn Rats
por: Park, Hyun-Kyung, et al.
Publicado: (2011)

The Effect of Hypoxic Preconditioning on Induced Schwann Cells under Hypoxic Conditions
por: Chen, Ou, et al.
Publicado: (2015)

The role of long non-coding RNAs in genome formatting and expression
por: Angrand, Pierre-Olivier, et al.
Publicado: (2015)

The Polycomb Group Protein Pcgf1 Is Dispensable in Zebrafish but Involved in Early Growth and Aging
por: Dupret, Barbara, et al.
Publicado: (2016)

Genetic Engineering of Zebrafish in Cancer Research
por: Raby, Ludivine, et al.
Publicado: (2020)

The Polycomb Orthologues in Teleost Fishes and Their Expression in the Zebrafish Model
por: Raby, Ludivine, et al.
Publicado: (2020)

Nonstochastic effects of ionizing radiation
por: Commission Internationale de Protection contre les Radiations
Publicado: (1984)

The biological effects of ionizing radiation
por: Streit-Bianchi, Marilena
Publicado: (2008)

Hyperoxia sensitizes hypoxic HeLa cells to ionizing radiation by downregulating HIF-1α and VEGF expression
por: Dong, Dan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_huseremj80kb4ptrtoitgtdpl4